The bacterial vaccine for whooping cough (pertussis) is known to cause local reactions in the majority of recipients and, less frequently, serious systemic toxicity reactions including brain damage and death (7, 28) . The vaccine consists of whole killed Bordetella pertussis cells in which some of the toxic factors of the microorganism are still active (14, 15) . These toxic factors include pertussis toxin (23, 38) (also called islet-activating protein, lymphocytosis-promoting factor, or pertussigen) and extracytoplasmic adenylate cyclase (9, 17, 18, 42) . Although the current vaccine affords significant protection, the identity of the antigens necessary and sufficient to confer immunity has not been established (34) . Recent efforts to develop a safe and effective vaccine have been frustrated by lack of information on the pathogenesis of the natural infection (32, 33) . We have attempted to study B. pertussis pathogenesis by generating a series of mutants, each deficient in a single factor believed to be important for virulence. Studies with mutations in a single gene would be useful for determining the contribution of a particular microbial determinant in the disease process.
B. pertussis has the ability to undergo a form of phase variation in which the cells no longer produce several determinants associated with the disease (12, 21, 22, 30, 31) . These factors include pertussis toxin, extracytoplasmic adenylate cyclase, filamentous hemagglutinin (FHA), pili, cytochrome d-629, and several outer membrane proteins (12) . We have found that the high frequent of occurrence of this phase shift makes it difficult to characterize mutants genetically by recombinational methods due to the high background of spontaneous negative mutants (41) . The advantage of transposon mutagenesis is that usually only a single gene is mutated and the site of the insertion is marked both physically by the transposon DNA and genetically with an antibiotic resistance. In a previous study we described a plasmid vector that could be used to introduce transposons into the B. pertussis chromosome (41) . In the present study, we used a similar transposon delivery system and transposon TnS as a mutagen, and herein we describe several mutants with single-site mutations that are deficient in virulence-associated factors of B. pertussis.
MATERIALS AND METHODS
Bacterial strains and cultivation conditions. The B.
pertussis strains used in this study are listed in Table 1 . The bacteria were grown in Stainer-Scholte (SS) broth .str-3 rif-3, derivative of Tohama I a Allelic designations and resistance genes of pRK2013 are as follows: nal, nalidixic acid resistance; str, streptomycin resistance; rif, rifampin resistance; kan, kanamycin resistance.
or on Bordet-Gengou (BG) plates as described previously (40, 41) . During the course of this study it became apparent that not all commercially available lots of BG agar permitted the identification of hemolysis. In this study we used Difco BG agar base (Difco Laboratories, Detroit, Mich.) lot 689592 supplemented with 15% sheep erythrocytes to detect hemolysis. Genetic matings were performed as previously described (41) . When selecting for resistant bacteria, BG plates were supplemented with antibiotics at the following concentrations: kanamycin, 25 ,ug/ml; and nalidixic acid, 50 p.g/ml.
Construction of a plasmid for generating TnS insertion mutants. We have previously shown that ColEl plasmids were not maintained in B. pertussis, and chimeric plasmids containing a ColEl replication origin and P incompatibility plasmid conjugation genes could be used to introduce transposons Tn7 and Tn501 into B. pertussis (41) . We constructed a similar chimeric plasmid, pUW964, for introducing TnS into B. pertussis (Fig. 1) . Initially, we used plasmid pRKTV5 (from N. Panapoulos, University of California, Berkeley), a derivative of plasmid pRK2013 (13) in which a different, poorly transposable kanamycin resistance determinant had been inactivated by a Tn7 insertion. Tn7 encodes resistance to the antibiotics trimethoprim, spectinomycin, and streptomycin. TnS was transposed onto plasmid pRKTV5 by using a defective lambda derivative by the method of Ruvkun and Ausubel (36) .
Hemagglutination assays. B. pertussis cells were grown in SS broth for 2 days. A 100-,ul sample of cells was mixed with 100 ,ul of sheep erythrocytes, washed, and suspended to 0.5% in phosphate-buffered saline (pH 7.4) in microtiter plates. The plates were incubated overnight at 4°C and then scored for hemagglutination.
Adenylate cyclase assays. Enzymatic adenylate cyclase assays, measuring [o-32P]ATP conversion to 32p-labeled cyclic AMP, were performed as described by Hewlett et al. (17) with and without 1 ,uM calmodulin. SDS-PAGE and Western blotting. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with 10% acrylamide slab gels was performed as described by Laemmli (27) . Bacteria from 3-day-old SS cultures were concentrated by centrifugation and suspended in final sample buffer to approximately 4.8 optical density units at 580 nm. The samples were boiled, and 25-,ul samples were loaded on each lane. Western blotting (4) with electrophoretic transfer to nitrocellulose, incubation with antisera, and incubation with 251I-labeled staphylococcal protein A (New England Nuclear Corp., Boston, Mass.) was performed as described by Cohen and Falkow (8) . Rabbit immunoglobulin G specific for FHA was a gift from J. Cowell, Division of Bacterial Products, National Center for Drugs and Biologics. The antiserum was further purified by adsorbing with the avirulent strain BP326.
Dermonecrotic toxin assay. The dermonecrotic toxin was assayed in infant mice by nuchal injection of whole organisms as described previously (10) .
Biological assays for pertussis toxin. The Chinese hamster ovary (CHO) cell assay (16) was used to test for the presence of pertussis toxin. Ten microliters of supernatant SS medium from 48-h cultures of each mutant was added to CHO cells in microtiter wells containing 200 p.l of F-12 medium (GIBCO Laboratories, Grand Island, N.Y.) with 1% serum. Nontoxigenic mutants were identified by their failure to elicit the characteristic cell cluster morphology. All mutants altered in toxin activity were further characterized by injecting supernatant culture medium (0.4 ml) intravenously into the tail vein of female CFW mice and testing for histamine sensitization 48 h later by intraperitoneal injection of 1 mg of histamine base (29) .
Restriction digests and filter hybridization. Chromosomal DNA was prepared as previously described (19) . Restriction endonucleases were used under conditions recommended by the supplier (Bethesda Research Laboratories, Gaithersburg, Md.). Electrophoresis of cleaved DNA in 0.7% agarose with Trisacetate buffer, transfer to nitrocellulose, and hybridization with a 32P-labeled DNA probe were performed as previously described (41) . The Tn5-specific DNA probe was prepared from the internal HindlIl fragment of TnS, which contains all of the FIG. 1 . Restriction map of plasmid pUW964. The numbers inside the circle represent plasmid coordinates in kilobases starting from the EcoRI site used to join ColEl with the pRK212 sequences in the construction of pRK2013 (13 (35) . To prepare this fragment, ColE1::TnS plasmid DNA was restricted with HindIII, and the two fragments were separated by electrophoresis. The fragment containing the TnS sequence was cut from the gel, electroeluted, and nick translated as previously described (41) .
Nomenclature. Genotypes and phenotypes of TnS insertion mutants were named according to the guidelines of Campbell et al. (5) . Insertions in sites with undefined phenotypes were named according to the convention of Chumley et al. (6) . We have attempted to use three-letter mnemonics for genetic alleles according to the standard nomenclature for Escherichia coli (1 pertussis, because of the limited host range for ColEl incompatibility group plasmids.
The TnS-containing "suicide plasmid" pUW964 was introduced into B. pertussis strain BP338 by plate matings with the E. coli donor for 4 to 6 h on BG plates (41) . We found that the efficiency of mating was increased when the BG plates were supplemented with 10 mM MgSO4. Tn5 insertions into the B. pertussis chromosome were selected on BG plates containing nalidixic acid and kanamycin. Presumptive Tn5 insertion mutants were purified by streaking for single colony isolates on BG. To confirm that the plasmid was not maintained in the recipient cells, the loss of trimethoprim and spectinomycin resistance encoded by the other plasmid marker, Tn7, was scored. To insure that each insertion was independent, only one kanamycinresistant mutant from a single mating was retained. The properties of the TnS mutants that we chose to characterize are summarized in Table 2 .
Isolation of an avirulent-phase mutant. One Tn5 insertion mutant, BP347, did not produce hemolysin and when further characterized was also negative for hemagglutination, pertussis toxin production, dermonecrotic toxin production, and adenylate cyclase production (Tables 2  and 3 ) and seemed to be identical to an avirulentphase mutant. We used this mutant and BP326, a derivative of Tohama III, as negative controls when we assayed for biological activities associated with virulence.
Identification of hemolysin mutants. Several other nonhemolytic mutants were obtained (Table 2). One mutant, BP352, seemed to have reduced hemolytic activity, but was not totally negative. Unlike BP347, all of these hemolysin mutants were positive when assayed for production of pertussis toxin, dermonecrotic toxin, and FHA. However, when these nonhemolytic mutants were assayed for adenylate cyclase production, variable results were obtained ( Table  3 ). The adenylate cyclase activity of B. pertussis is characterized by the unique properties of being localized to an extracytoplasmic compartment (17) and of being stimulated by the eucaryotic protein calmodulin (42) . Whole cell and supernatant fractions were assayed for adenylate cyclase in the presence and absence of calmodulin. The parental strain, BP338, contained high levels of enzyme activity in both fractions. Two nonhemolytic mutants, strains BP349, and BP352, had significant levels of enzyme activity. Mutants BP350 and BP351 had only trace levels of activity, and strain BP348 was totally negative for adenylate cyclase activity. The avirulent-phase mutants BP326 and BP347 were also devoid of adenylate cyclase activity. A TnS insertion mutant with no obvious change in phenotype, BP358, had nearly wildtype levels of activity, both cell associated and in the supernatant fraction, demonstrating that the change in adenylate cyclase levels was not due to the presence of TnS alone.
We tested all of the nonhemolytic mutants for phenotypic complementation. If a particular process, such as hemolysis, requires the interaction of two proteins, two mutants each deficient in a different factor will regain the activity when mixed together if each supplies the factor the other lacks. We cross-streaked the nonhemolytic mutants as well as the avirulent-phase mutant, BP347, in all possible combinations against each other on BG plates and scored for hemolysis production. No hemolysis was observed with any combination of nonhemolytic strains, indicating that complementation did not occur under these experimental conditions.
Isolation and characterization of non-hemagglutinating mutants. B. pertussis possesses two protein factors which mediate hemagglutination (20, 37) , FHA and pertussis toxin. The presence of two factors with the same activity could obscure an assay for single mutants. We avoided this difficulty by assaying for hemagglutination with sheep erythrocytes, which efficiently detect hemagglutination mediated by FHA, but not that mediated by pertussis toxin (20) . Kanamycinresistant strains were grown in SS medium and then assayed for hemagglutination. Two mutants, BP353 and BP354, were negative for hemagglutination and were further characterized.
Both mutants were positive for pertussis toxin production by the CHO cell assay and also produced hemolysin and adenylate cyclase (Tables 2 and 3). However, when we compared the levels of adenylate cyclase activity with that of the parental strain, BP338, both mutants had reduced cell-associated activity, but higher levels of enzyme activity, in the supernatant fraction. Unlike the nonhemolytic mutants, the adenylate cyclase activity in these mutants appears to be quite high, but the distribution of the activity between the different cellular compartments has been altered.
The protein profiles of whole cell preparations of the mutants and wild-type strains were characterized by SDS-PAGE (Fig. 2) . The virulentphase parental strain produced a large polypeptide at molecular mass of about 200,000 daltons detected by Coomassie straining. The protein was present in reduced amounts in mutant BP354 and was absent in mutant BP353 and the avirulent phase mutants BP326 and BP347. Based on previous data (11) we presumed that this protein was the FHA. To confirm this, we used the Western blotting technique (Fig. 3) . The rabbit antiserum to FHA was able to block hemagglutination when the parental strain, BP338, was incubated with sheep erythrocytes. When whole cell protein preparations of BP338 were separated by electrophoresis, two bands of 130,000 and 100,000 daltons in addition to the 200,000-dalton protein, were detected which reacted specifically with the antiserum to FHA (Fig. 3, lane b) . These bands were missing or reduced in the mutants BP353 and BP354 as well as in the avirulent-phase strain BP326 (Fig. 3,   lanes c, d, and a, respectively) . These data suggest that mutants BP353 and BP354 are de- fective in the structural gene for FHA or a gene necessary for its expression.
Pertussis toxin mutants. Kanamycin-resistant TnS insertion strains were screened for pertussis toxin production by the CHO cell assay. Two mutants, BP356 and BP357, had no detectable activity in this biological assay. These mutants also failed to produce histamine sensitization in CFW mice (Table 4) . Further characterization of these mutants, however, detected cell-associated pertussis toxin. Since the amount of material employed was 5 to 100 times that required to elicit responses with the wild-type, parental strain, it appears that these mutants are partially deficient in toxin production or are unable to process and transport it normally.
Physical characterization of the Tn5 insertion mutants. The location of TnS insertion mutations can be determined by using a 32P-labeled DNA probe specific for TnS to hybridize to chromosomal DNA restriction fragments separated by electrophoresis. The hybridizations were performed on various combinations of mutants to determine whether the mutant phenotypes were due to single insertions and whether the insertions occurred within the same restriction fragment for mutants that had the same phenotype.
Large fragments of chromosomal DNA were prepared and restricted with endonuclease EcoRI or ClaI. These two enzymes were used because Tn5 does not encode the restriction sequence for either of these enzymes. TnS insertions occurring within the same restriction fragment in the B. pertussis chromosome should comigrate.
All of the mutants analyzed contained a single EcoRI restriction fragment that was homologous to TnS (Fig. 4) , including BP347 (Fig. 4f) , the avirulent-phase mutant that had lost several of the determinants associated with pathogenicity. The FHA-deficient mutants BP353 and BP354 had restriction fragments containing TnS that appeared to comigrate (Fig. 4a and b) , as did the pertussis toxin mutants BP356 and BP357 ( Fig.  4g and h) .
Different results were obtained when three nonhemolytic mutants, BP348, BP349, and BP350, were compared. The TnS-containing fragment of BP348 (Fig. 4c) did not appear to comigrate with that of BP349 and BP350 (Fig. 4d  and e a CFW female mice were injected intravenously in the tail with culture medium or phosphate-buffered saline alone. Mice were challenged 48 h later by the intraperitoneal injection of 1 mg of histamine.
and BP350 had adenylate cyclase activity, even though the levels of activity were quite different from each other and from the parental strain, BP338. BP348, however, was the nonhemolytic mutant that totally lacked adenylate cyclase activity. From these data we conclude that the site of the TnS insertion in BP348 is separated by at least one EcoRI restriction site from the site of insertion in BP349 and BP350, and these two regions may not be genetically linked at all.
Restriction fragments of chromosomal DNA were also prepared by using ClaI and hybridized with the TnS probe. was removed from the lipid. The remaining aminolipid could no longer mediate hemagglutination, but had acquired hemolytic activity. Whether this activity is related to the hemolysis observed on BG plates is unknown; however, both virulent-and avirulent-phase bacteria synthesize this lipid (24) , but only virulent-phase bacteria are hemolytic. The availability of the nonhemolytic mutants isolated in this study should help clarify the biochemical nature of the hemolysin determinant.
We have characterized mutants deficient in FHA that do not produce three large-molecularmass proteins present in the wild-type strain. These proteins migrate at 200,000, 130,000, and 100,000 daltons and cross-react with antisera to FHA. Cowell et al. have purified FHA and have shown that the purified material was separated by SDS-PAGE as three high-molecular-mass polypeptide species at 160,000, 115,000, and 90,000 daltons (11) . The differences in the molecular mass determinations may be due to different conditions of electrophoresis. Alternatively, the differences could be due to the fact that we characterized FHA isolated from whole cell preparations as opposed to the FHA purified from the supernatant that was characterized by Cowell et al. (11) . The three protein bands may correspond to aggregates of FHA with other proteins, or processed forms of FHA. One of the mutants that failed to hemagglutinate sheep erthrocytes did not produce these proteins, whereas the other synthesized them in reduced amounts. Both mutants seemed to contain a single TnS insertion within the same restriction fragment and may be encoded in an operon. The reduced protein levels in one mutant could be due to an insertion that inactivated a region necessary for the expression of the structural gene, whereas the other mutant could have an insertion within the structural gene itself. Watanabe and Nakase (39) using UV mutagenesis, have also isolated mutants that failed to produce hemagglutination.
They did not characterize their mutants biochemically.
All of the mutant phenotypes that we have isolated are associated with secreted products. One might expect that negative phenotypes could be due to either defects in the structural gene or secretory defects, and that the loss of one factor could influence the level of expression of another. The FHA mutants (BP353 and BP354) were able to produce hemolysin, pertussis toxin, and adenylate cyclase; however, they seemed to contain more adenylate cyclase activity in the supernatant fraction and less whole cell-associated activity than did the parental strain, BP338. This difference seems to reflect a difference in compartmentalization of adenylate cyclase activity and not a reduction in total enzyme activity. In contrast, a nonhemolytic mutant (BP349) appeared to have proportionately reduced activity in both the supernatant and cellular compartments. Since both FHA and adenylate cyclase are extracytoplasmic proteins, the loss of one activity could result in more efficient release of the other by either an active or passive process. Bassford and Beckwith (2) have shown that the levels of secretion of extracellular proteins are interrelated. When synthesis of a ,B-galactosidase fusion protein which contained a leader sequence, but which could not be effectively secreted, was induced, secretion of other proteins was also impaired.
The use of transposons as mutagens in B. pertussis has provided us with a series of strains deficient in a single virulence determinant. We believe that this is the first report demonstrating that mutants deficient in a single virulence determinant can be isolated for several of the different B. pertussis virulence factors. The different classes of mutants that we have isolated provide preliminary evidence for the genetic organization of the virulence genes of B. pertussis. The series of TnS mutants that had lost only a single trait, such as BP353 (the FHA mutant), BP356 (the pertussis toxin mutant), and BP349 (the nonhemolytic mutant), demonstrate that hemolysin, FHA, and pertussis toxin can be mutated independently. These mutants still retained dermonecrotic toxin, indicating that this gene is also independent from the others. The loss of all virulent phase-associated traits due to a single TnS insertion in mutants such as BP347 supports the hypothesis that there is a single genetic region, presumably trans acting, that is required for the expression of the other genes. We hope to use the Tn5-encoded kanamycin resistance as a genetic marker to clone the restriction fragment containing the gene of interest. The surrounding B. pertussis sequences can then be used as a DNA probe to isolate the wild-type genes. The cloned genes should help answer many questions concerning the molecular organization of the B. pertussis virulence determinants.
The TnS mutants should also prove useful in experimental infections to determine the precise contribution of each individual virulence factor to the pathogenesis of B. pertussis infection. We hope that such studies will help define which determinants of B. pertussis are important for generating host immunity to disease and thus would be candidates to be included in an acellular pertussis vaccine. 
